Morgillo F - Search Results

1

Immunotherapy for head and neck cancer: Present and future.

Fasano M, Corte CMD, Liello RD, Viscardi G, Sparano F, Iacovino ML, Paragliola F, Piccolo A, Napolitano S, Martini G, Morgillo F, Cappabianca S, Ciardiello F. Fasano M, et al. Among authors: morgillo f. Crit Rev Oncol Hematol. 2022 Jun;174:103679. doi: 10.1016/j.critrevonc.2022.103679. Epub 2022 Apr 6. Crit Rev Oncol Hematol. 2022. PMID: 35395371 Free article. Review.

2

Pegylated liposomal doxorubicin: pharmacologic and clinical evidence of potent antitumor activity with reduced anthracycline-induced cardiotoxicity (review).

Orditura M, Quaglia F, Morgillo F, Martinelli E, Lieto E, De Rosa G, Comunale D, Diadema MR, Ciardiello F, Catalano G, De Vita F. Orditura M, et al. Among authors: morgillo f. Oncol Rep. 2004 Sep;12(3):549-56. Oncol Rep. 2004. PMID: 15289836 Review.

3

Combination of standard chemotherapy and targeted agents.

Bareschino MA, Morgillo F, Ciardiello F. Bareschino MA, et al. Among authors: morgillo f. J Thorac Oncol. 2007 May;2(5 Suppl):S19-23. doi: 10.1097/01.JTO.0000268636.02709.b4. J Thorac Oncol. 2007. PMID: 17457224 Free article. Review. No abstract available.

4

Primary and acquired resistance to anti-EGFR targeted drugs in cancer therapy.

Morgillo F, Bareschino MA, Bianco R, Tortora G, Ciardiello F. Morgillo F, et al. Differentiation. 2007 Nov;75(9):788-99. doi: 10.1111/j.1432-0436.2007.00200.x. Epub 2007 Jul 2. Differentiation. 2007. PMID: 17608727 Review.

5

Chronic inflammation and oxidative stress in human carcinogenesis.

Federico A, Morgillo F, Tuccillo C, Ciardiello F, Loguercio C. Federico A, et al. Among authors: morgillo f. Int J Cancer. 2007 Dec 1;121(11):2381-6. doi: 10.1002/ijc.23192. Int J Cancer. 2007. PMID: 17893868 Free article. Review.

6

The use of xenograft models for the selection of cancer treatments with the EGFR as an example.

Troiani T, Schettino C, Martinelli E, Morgillo F, Tortora G, Ciardiello F. Troiani T, et al. Among authors: morgillo f. Crit Rev Oncol Hematol. 2008 Mar;65(3):200-11. doi: 10.1016/j.critrevonc.2007.10.003. Crit Rev Oncol Hematol. 2008. PMID: 18389522 Review.

7

Sequence-dependent, synergistic antiproliferative and proapoptotic effects of the combination of cytotoxic drugs and enzastaurin, a protein kinase Cbeta inhibitor, in non-small cell lung cancer cells.

Morgillo F, Martinelli E, Troiani T, Laus G, Pepe S, Gridelli C, Ciardiello F. Morgillo F, et al. Mol Cancer Ther. 2008 Jun;7(6):1698-707. doi: 10.1158/1535-7163.MCT-07-0547. Mol Cancer Ther. 2008. PMID: 18566241

8

Implications for KRAS status and EGFR-targeted therapies in metastatic CRC.

Normanno N, Tejpar S, Morgillo F, De Luca A, Van Cutsem E, Ciardiello F. Normanno N, et al. Among authors: morgillo f. Nat Rev Clin Oncol. 2009 Sep;6(9):519-27. doi: 10.1038/nrclinonc.2009.111. Epub 2009 Jul 28. Nat Rev Clin Oncol. 2009. PMID: 19636327 Review.

9

Antitumor activity of bortezomib in human cancer cells with acquired resistance to anti-epidermal growth factor receptor tyrosine kinase inhibitors.

Morgillo F, D'Aiuto E, Troiani T, Martinelli E, Cascone T, De Palma R, Orditura M, De Vita F, Ciardiello F. Morgillo F, et al. Lung Cancer. 2011 Mar;71(3):283-90. doi: 10.1016/j.lungcan.2010.06.005. Lung Cancer. 2011. PMID: 20619923 Retracted.

10

Vascular endothelial growth factor in pleural fluid for differential diagnosis of benign and malignant origin and its clinical applications.

Fiorelli A, Vicidomini G, Di Domenico M, Napolitano F, Messina G, Morgillo F, Ciardiello F, Santini M. Fiorelli A, et al. Among authors: morgillo f. Interact Cardiovasc Thorac Surg. 2011 Mar;12(3):420-4. doi: 10.1510/icvts.2010.250357. Epub 2010 Dec 20. Interact Cardiovasc Thorac Surg. 2011. PMID: 21172937

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

168 results

Search Page